Stay updated with breaking news from Path Stock Down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totalling 24,000 shares, a drop of 45.9% from the April 30th total of 44,400 shares. Currently, 1.5% of the company’s stock are short sold. Based on an […]
Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have received an average rating of “Moderate Buy” from the eighteen analysts that are covering the firm, Marketbeat.com reports. Nine investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month target price among […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital boosted their Q2 2024 earnings per share estimates for Bio-Path in a report released on Wednesday, May 15th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings per share of ($2.06) for the quarter, up from their previous estimate of ($4.60). […]
Powell Investment Advisors LLC bought a new position in shares of UiPath Inc. (NYSE:PATH – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,190 shares of the healthcare company’s stock, valued at approximately $402,000. Other institutional […]
UiPath Inc. (NYSE:PATH – Get Free Report)’s stock price traded up 0.2% during mid-day trading on Wednesday . The stock traded as high as $21.73 and last traded at $21.61. 1,595,202 shares were traded during mid-day trading, a decline of 83% from the average session volume of 9,332,723 shares. The stock had previously closed at […]